Cardinal Health (NYSE: CAH) will receive $29.2 million under a new U.S. Department of Defense contract, with Hamilton Medical and Zoll Medical also securing contracts in the tens of millions of dollars.
Cardinal Health’s contract win, announced Sept. 29, comes nearly eight months after Dublin, Ohio–based Cardinal Health secured a $2.25 billion surgical supplies contract renewal with the U.S. military, with Owens & Minor winning another $1.125 billion as part of the deal.
In April, Cardinal Health won a $46.5 million fixed-price DoD contract to supply laboratory supplies and wares.
The $29 million contract announced last week is a nine-month base contract with eight one-year and one 15-month option periods. Customers include the Army, Navy, Air Force, Marine Corps and federal civilian agencies.
Cardinal Health wasn’t the only medtech company scoring multimillion-dollar DoD contracts.
Hamilton Medical (U.S. headquarters in Reno, Nev.) and Zoll Medical (Chelmsford, Mass.) will receive $40.0 million and $30.7 million respectively under five-year contracts for medical equipment and medical equipment spare parts, DoD announced Sept. 29. The contracts have no option periods. Customers include the Army, Navy, Air Force and Marine Corps, as well as the U.S. Department of Health and Human Services.
In other news, biotechnology and regenerative medicine company Humacyte (Research Triangle Park, N.C.) today announced a $3.4 million D0D contract to help support additional clinical sites for Humacyte’s Phase II vascular trauma trial in the U.S. Humacyte has an investigational human acellular vessel called Humacyl. The company announced last week that the California Institute for Regenerative Medicine is giving it $14.1 million to support a clinical trial comparing Humacyl to arteriovenous fistulas.